TRUPANION, INC. — Director's Dealing 2020

Jun 1, 2020

SEC Form 4/A — Form 4/A

Issuer: TRUPANION, INC. (TRUP)
CIK: 0001371285
Period of Report: 2019-11-13

Reporting Person: LEVITAN DAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-13	Common Stock	J	211947	—	Disposed	638881	Indirect
2019-11-13	Common Stock	J	2075	—	Acquired	7854	Indirect
2019-11-13	Common Stock	J	29061	—	Disposed	87599	Indirect
2019-11-13	Common Stock	J	8992	—	Disposed	27106	Indirect
2019-11-13	Common Stock	J	90	—	Acquired	7944	Indirect
2019-11-13	Common Stock	J	1252	—	Disposed	6692	Indirect
2019-11-13	Common Stock	J	109	—	Acquired	4507	Indirect
2019-11-13	Common Stock	J	4577	—	Acquired	79628	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23000	Indirect

Footnotes

F1: Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 211,947 shares of common stock of the issuer to its partners on November 13, 2019.

F2: Shares are owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F3: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F4: MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 29,061 shares of common stock of the issuer to its partners on November 13, 2019.

F5: Shares are owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F6: Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 8,992 shares of common stock of the issuer to its partners on November 13, 2019.

F7: Shares are owned directly by Maveron Entrepreneurs. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Entrepreneurs, and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F8: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F9: Maveron GP distributed for no consideration 1,252 shares of common stock of the issuer to its members on November 13, 2019.

F10: Shares owned directly by Maveron GP.

F11: Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates.

F12: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F13: Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron Associates.

F14: Shares are held by a trust the holdings of which are attributable to the reporting person.